Franklin Genomic Advancements Etf Price on July 17, 2024
| HELX Etf | USD 29.53 0.29 0.99% |
Below is the normalized historical share price chart for Franklin Genomic Advancements extending back to February 27, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Franklin Genomic stands at 29.53, as last reported on the 22nd of November, with the highest price reaching 29.54 and the lowest price hitting 29.19 during the day.
If you're considering investing in Franklin Etf, it is important to understand the factors that can impact its price. Franklin Genomic Adv secures Sharpe Ratio (or Efficiency) of -0.15, which denotes the etf had a -0.15% return per unit of standard deviation over the last 3 months. Franklin Genomic Advancements exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Franklin Genomic's Mean Deviation of 0.8691, coefficient of variation of (615.67), and Standard Deviation of 1.19 to check the risk estimate we provide.
Franklin Etf price history is provided at the adjusted basis, taking into account all of the recent filings.
3 y Volatility 22.91 | 200 Day MA 31.8847 | 1 y Volatility 20.7 | 50 Day MA 31.5801 | Inception Date 2020-02-25 |
Franklin |
Sharpe Ratio = -0.155
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HELX |
Estimated Market Risk
| 1.21 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Franklin Genomic is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Franklin Genomic by adding Franklin Genomic to a well-diversified portfolio.
Average Mkt Cap Mil 23.5 K |
Franklin Genomic Valuation on July 17, 2024
It is possible to determine the worth of Franklin Genomic on a given historical date. On July 17, 2024 Franklin was worth 33.69 at the beginning of the trading date compared to the closed value of 33.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Franklin Genomic etf. Still, in general, we apply an absolute valuation method to find Franklin Genomic's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Franklin Genomic where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Franklin Genomic's related companies.
| Open | High | Low | Close | Volume | |
| 33.86 | 33.98 | 33.81 | 33.98 | 7,600 | |
07/17/2024 | 33.69 | 33.78 | 33.33 | 33.37 | 3,200 |
| 33.35 | 33.35 | 32.44 | 32.44 | 1,100 |
| Backtest Franklin Genomic | | | Franklin Genomic History | | | Franklin Genomic Valuation | Previous | Next |
Franklin Genomic Trading Date Momentum on July 17, 2024
| On July 18 2024 Franklin Genomic Advancements was traded for 32.44 at the closing time. The top price for the day was 33.35 and the lowest listed price was 32.44 . The trading volume for the day was 1.1 K. The trading history from July 18, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.79% . The overall trading delta against the current closing price is 0.18% . |
Franklin Genomic Adv Fundamentals Correlations and Trends
By evaluating Franklin Genomic's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Franklin Genomic's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Franklin financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Franklin Genomic Etf history
Franklin Genomic investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Franklin is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Franklin Genomic Adv will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Franklin Genomic stock prices may prove useful in developing a viable investing in Franklin Genomic
Under normal market conditions, the fund invests at least 80 percent of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. Franklin Genomic is traded on BATS Exchange in the United States.
Franklin Genomic Etf Technical Analysis
Franklin Genomic technical etf analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, etf market cycles, or different charting patterns.
Price Boundaries
Franklin Genomic Period Price Range
Low | November 22, 2024
| High |
0.00 | 0.00 |
Franklin Genomic Advancements cannot be verified against its exchange. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Franklin Genomic November 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Franklin Genomic etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Franklin Genomic shares will generate the highest return on investment. By undertsting and applying Franklin Genomic etf market strength indicators, traders can identify Franklin Genomic Advancements entry and exit signals to maximize returns
Franklin Genomic Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Franklin Genomic's price direction in advance. Along with the technical and fundamental analysis of Franklin Etf historical price patterns, it is also worthwhile for investors to track various predictive indicators of Franklin to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (0.34) | |||
| Treynor Ratio | (0.20) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Franklin Genomic Advancements. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
The market value of Franklin Genomic Adv is measured differently than its book value, which is the value of Franklin that is recorded on the company's balance sheet. Investors also form their own opinion of Franklin Genomic's value that differs from its market value or its book value, called intrinsic value, which is Franklin Genomic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Franklin Genomic's market value can be influenced by many factors that don't directly affect Franklin Genomic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Franklin Genomic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Franklin Genomic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Franklin Genomic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.